Hostname: page-component-78c5997874-lj6df Total loading time: 0 Render date: 2024-11-13T10:24:35.928Z Has data issue: false hasContentIssue false
  • English
  • Français

Bisphosphonate-induced osteonecrosis of the ear canal: our experience and a review of the literature

Published online by Cambridge University Press:  28 February 2018

L McCadden ,
C G Leonard  and
W J Primrose
L McCadden*
Affiliation:
ENT Departments, Royal Victoria Hospital, Belfast, and Craigavon Area Hospital, NorthernIreland, UK
C G Leonard
Affiliation:
ENT Departments, Royal Victoria Hospital, Belfast, and Craigavon Area Hospital, NorthernIreland, UK
W J Primrose
Affiliation:
ENT Departments, Royal Victoria Hospital, Belfast, and Craigavon Area Hospital, NorthernIreland, UK
*
Address for correspondence: Mr Luke McCadden, 35 Marlborough Park Central, Belfast BT9 6HN, Northern Ireland, UK E-mail: lukemccadden@doctors.org.uk
Get access Rights & Permissions [Opens in a new window]

Abstract

Background:

Oesophageal disorders and osteonecrosis of the jaw are recognised complications of the commonly prescribed medication bisphosphonate. Despite these diagnoses being seen comparatively frequently within the ENT clinic, osteonecrosis of the external ear is a less well reported complication.

Methods:

The current literature is reviewed and our experience with six cases of bisphosphonate-related ear canal osteonecrosis is presented.

Results:

Six cases were identified as suffering from ear canal osteonecrosis as a result of bisphosphonate treatment. One of our cases suffered bilateral ear canal osteonecrosis after only 20 months of oral alendronic acid treatment. Management ranged from bisphosphonate cessation and topical treatment, to surgical debridement in the operating theatre.

Conclusion:

Bisphosphonate-related ear canal osteonecrosis is undoubtedly under-diagnosed. For such a commonly prescribed medication, the risks and side effects of bisphosphonate should be better known and long-term treatment should be avoided if possible.

Keywords

OsteonecrosisBisphosphonatesOtologyComplication
Type
Clinical Records
Information
The Journal of Laryngology & Otology , Volume 132 , Issue 4 , April 2018 , pp. 372 - 374
Copyright
Copyright © JLO (1984) Limited 2018 

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

1Das, S, Crockett, JC. Osteoporosis – a current view of pharmacological prevention and treatment. Drug Des Devel Ther 2013;7:435–48Google ScholarPubMed
2Whitaker, M, Guo, J, Kehoe, T, Benson, G. Bisphosphonates for osteoporosis - where do we go from here? N Engl J Med 2012;366:2048–51Google Scholar
3Barasch, A, Cunha-Cruz, J, Curro, FA, Hujoel, P, Sung, AH, Vena, D et al. Risk factors for osteonecrosis of the jaws: a case-control study from the CONDOR dental PBRN. J Dent Res 2011;90:439–44CrossRefGoogle ScholarPubMed
4Polizzotto, M, Cousins, V, Schwarer, A. Bisphosphonate-associated osteonecrosis of the auditory canal. Br J Haematol 2006;132:114Google Scholar
5Froelich, K, Radeloff, A, Kohler, C, Mlynski, R, Muller, J, Hagen, R et al. Bisphosphonate-induced osteonecrosis of the external ear canal: a retrospective study. Eur Arch Otolaryngol 2011;268:1219–25CrossRefGoogle ScholarPubMed
6Marx, RE. Uncovering the cause of “phossy jaw” circa 1858 to 1906: oral and maxillofacial surgery closed case files-case closed. J Oral Maxillofac Surg 2008;66:2356–63CrossRefGoogle ScholarPubMed
7Salzman, R, Hoza, J, Perina, V, Starek, I. Osteonecrosis of the external auditory canal associated with oral bisphosphonate therapy: case report and literature review. Otol Neurotol 2013;34:209–13Google Scholar
8Rogers, SN, Palmer, NO, Lowe, D, Randall, C. United Kingdom nationwide study of avascular necrosis of the jaws including bisphosphonate-related necrosis. Br J Oral Maxillofac Surg 2015;53:176–82Google Scholar
9Sun, K, Liu, JM, Sun, HX, Lu, N, Ning, G. Bisphosphonate treatment and risk of esophageal cancer: a meta-analysis of observational studies. Osteoporos Int 2013;24:279–86Google Scholar
10Morden, NE, Munson, JC, Smith, J, Mackenzie, TA, Liu, SK, Tosteson, AN. Oral bisphosphonates and upper gastrointestinal toxicity: a study of cancer and early signals of esophageal injury. Osteoporos Int 2015;26:663–72CrossRefGoogle ScholarPubMed